Rare variants in the complement factor H-related protein 5 gene contribute to genetic susceptibility to IgA nephropathy

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2894-2905

  Zhai, Ya Ling ^a,b   Meng, Si Jun ^a,b   Zhu, Li ^a,b,c   Shi, Su Fang ^a,b,c   Wang, Su Xia ^a,b,c   Liu, Li Jun ^a,b,c   Lv, Ji Cheng ^a,b,c   Yu, Feng ^a,b,c   Zhao, Ming Hui ^a,b,c   Zhang, Hong ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN 5; UNCLASSIFIED DRUG; COMPLEMENT; FHR5 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS;

ADULT; COMPLEMENT SYSTEM PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLOMERULONEPHRITIS, IGA; HUMANS; MALE;

EID: 84999762007     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010012     Document Type: Article

References (45)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987
2. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J: Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 60: 969-973, 2001
3. Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA,Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J: IgA nephropathy: Characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol 157: 129-133, 2007
4. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, CooperMD, Monteiro RC: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J ExpMed 194: 417-425, 2001
5. Lai KN, Tang SC, Leung JC: Recent advances in IgA nephropathy-the glomerulopodocytic-tubular communication. Adv Otorhinolaryngol 72: 40-44, 2011
6. Haas M: Histology and immunohistology of IgA nephropathy. J Nephrol 18: 676-680, 2005
7. Gharavi AG, Kiryluk K, ChoiM, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L,WangW, Wang Z, Yasuno K, GunelM,Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321-327, 2011
8. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J,Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A,Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG: Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 8: e1002765, 2012
9. Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT: Complement factor H related proteins (CFHRs). Mol Immunol 56: 170-180, 2013
10. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC: Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376: 794-801, 2010
11. Barbour TD, Pickering MC, Cook HT: Recent insights into C3 glomerulopathy. Nephrol Dial Transplant 28: 1685-1693, 2013
12. McRae JL, Cowan PJ, Power DA, Mitchelhill KI, Kemp BE, Morgan BP, Murphy BF: Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem 276: 6747-6754, 2001
13. McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL: Human factor Hrelated protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 174: 6250-6256, 2005
14. Kidney Disease: Improving Global Outcomes (KDiGO) Glomerulonephritis Work Group: KDiGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2: 209-217, 2012
15. Zhu L, Zhai YL,Wang FM, Hou P, Lv JC, XuDM, Shi SF, Liu LJ, Yu F, Zhao MH, Novak J, Gharavi AG, Zhang H: Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol 26: 1195-1204, 2015
16. Jokiranta TS, Hellwage J, Koistinen V, Zipfel PF, Meri S: Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem275: 27657-27662, 2000
17. Yu XQ, Li M, Zhang H, Low HQ,Wei X, Wang JQ, Sun LD, Sim KS, Li Y, Foo JN, Wang W, Li ZJ, Yin XY, Tang XQ, Fan L, Chen J, Li RS,Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ: A genomewide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44: 178-182, 2012
18. Diogo D, Kurreeman F, Stahl EA, Liao KP, Gupta N, Greenberg JD, Rivas MA, Hickey B, Flannick J, Thomson B, Guiducci C, Ripke S, Adzhubey I, Barton A, Kremer JM, Alfredsson L, Sunyaev S, Martin J, Zhernakova A, Bowes J, Eyre S, Siminovitch KA, Gregersen PK, Worthington J, Klareskog L, Padyukov L, Raychaudhuri S, Plenge RM; Consortium of Rheumatology Researchers of North America; Rheumatoid Arthritis Consortium International: Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes fromGWASs contribute to risk of rheumatoid arthritis. AmJ Hum Genet 92: 15-27, 2013
19. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, Boucher G, Ripke S, Ellinghaus D, Burtt N, Fennell T, Kirby A, Latiano A, Goyette P, Green T, Halfvarson J, Haritunians T, Korn JM, Kuruvilla F, Lagacé C, Neale B, Lo KS, Schumm P, Törkvist L, Dubinsky MC, Brant SR, Silverberg MS, Duerr RH, Altshuler D, Gabriel S, Lettre G, Franke A, D'Amato M, McGovern DP, Cho JH, Rioux JD, Xavier RJ, Daly MJ; National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC); United Kingdom Inflammatory Bowel Disease Genetics Consortium; International Inflammatory Bowel Disease Genetics Consortium: Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073, 2011
20. CoenenMJ, Hofstra JM, Debiec H, Stanescu HC,Medlar AJ, Stengel B, Boland-Augé A, Groothuismink JM, Bockenhauer D, Powis SH, Mathieson PW, Brenchley PE, Kleta R, Wetzels JF, Ronco P: Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 24: 677-683, 2013
21. Salant DJ: Genetic variants in membranous nephropathy: Perhaps a perfect stormrather than a straightforward conformeropathy?JAmSoc Nephrol 24: 525-528, 2013
22. Feehally J, FarrallM,BolandA,GaleDP, Gut I,Heath S, KumarA, Peden JF, Maxwell PH, Morris DL, Padmanabhan S, Vyse TJ, Zawadzka A, Rees AJ, Lathrop M, Ratcliffe PJ: HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 21: 1791-1797, 2010
23. Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, ChoiM, VerbitskyM, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, P?czek L, ZaniewM,Mizerska-WasiakM, Roszkowska-BlaimM, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, MetzgerM, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG: Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 46: 1187-1196, 2014
24. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89: 82-93, 2011
25. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD, Lin X: Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet 92: 841-853, 2013
26. Lee S,WuMC, Lin X: Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13: 762-775, 2012
27. Monteferrante G, Brioschi S, Caprioli J, Pianetti G, Bettinaglio P, Bresin E, Remuzzi G, Noris M: Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome. Mol Immunol 44: 1704-1708, 2007
28. Abrera-AbeledaMA, Nishimura C, Smith JL, Sethi S,McRae JL, Murphy BF, Silvestri G, Skerka C, Józsi M, Zipfel PF, Hageman GS, Smith RJ: Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 43: 582-589, 2006
29. Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, Amann K, Buettner M, Goodship T, Hugo C, Skerka C, Zipfel PF: Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest 124: 145-155, 2014
30. Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP: Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene. J Hum Genet 57: 459-464, 2012
31. Jönsen A, Nilsson SC, Ahlqvist E, Svenungsson E, Gunnarsson I, Eriksson KG, Bengtsson A, Zickert A, Eloranta ML, Truedsson L, Rönnblom L, Nordmark G, Sturfelt G, Blom AM: Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther 13: R206, 2011
32. Narendra U, Pauer GJ, Hagstrom SA: Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration. Mol Vis 15: 731-736, 2009
33. Goicoechea de Jorge E, Caesar JJ, Malik TH, Patel M, Colledge M, Johnson S, Hakobyan S, Morgan BP, Harris CL, Pickering MC, Lea SM: Dimerization of complement factor H-related proteins modulates complement activation in vivo. ProcNatlAcad SciUSA110: 4685-4690, 2013
34. Tortajada A, Yébenes H, Abarrategui-Garrido C, Anter J, García-Fernández JM, Martínez-Barricarte R, Alba-Domínguez M, Malik TH, Bedoya R, Cabrera Pérez R, López TrascasaM, PickeringMC, Harris CL, Sánchez-Corral P, Llorca O, Rodríguez de Córdoba S: C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. J Clin Invest 123: 2434-2446, 2013
35. Kavanagh D, Goodship T: Genetics and complement in atypical HUS. Pediatr Nephrol 25: 2431-2442, 2010
36. Mele C, Remuzzi G, Noris M: Hemolytic uremic syndrome. Semin Immunopathol 36: 399-420, 2014
37. Zhu L, Shi S, Liu L, Lv J, Zhang H: Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol 14: 21, 2013
38. Zhai YL, Zhu L, Shi SF, Liu LJ, Lv JC, Zhang H: Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy. PLoS One 9: e101779, 2014
39. Zhang JJ, Jiang L, Liu G, Wang SX, Zou WZ, Zhang H, Zhao MH: Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions. Nephrology (Carlton) 13: 712-720, 2008
40. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN, Deltas C: A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS One 7: e31021, 2012
41. Serino G, Sallustio F, Cox SN, Pesce F, Schena FP: Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J AmSoc Nephrol 23: 814-824, 2012
42. Murphy B, Georgiou T, Machet D, Hill P, McRae J: Factor H-related protein-5: A novel component of human glomerular immune deposits. Am J Kidney Dis 39: 24-27, 2002
43. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
44. Ma YC, Zuo L, Chen JH, LuoQ, Yu XQ, Li Y, Xu JS, Huang SM,Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937-2944, 2006
45. Haas M: Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. AmJ Kidney Dis 29: 829-842, 1997